Source:http://linkedlifedata.com/resource/pubmed/id/21262375
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-3-30
|
pubmed:abstractText |
The integrin ?2?1 plays an important role in force-transmitting cell-matrix interactions. It recognizes the peptide sequence GFOGER (O=4-hydroxy-proline) presented as trimer within a collagenous triple-helical framework. We produced the recombinant non-hydroxylated mini-collagen, termed FC3, which harbors the ?2?1 integrin recognition site. FC3 consists of a foldon-stabilized host triple helix of three chains with 10 GPP-repeats, into which the integrin binding motif was inserted. The triple-helical structure could further be stabilized by covalently cross-linking the three chains. Unlike collagen-I, FC3 lacks binding sites for matrix proteins and cellular receptors other than the collagen-binding integrins. It showed a preference for ?2?1 over ?1?1 integrin, especially when the chains were neither cross-linked nor prolyl-hydroxylated. Using FC3 as substratum for primary skin fibroblasts, we showed that the loss of ?2?1 integrin could not be compensated by other collagen-binding integrins, suggesting a major role of ?2?1 integrin in exerting sufficient mechanical force to induce or sustain cell spreading. Atomic force microscopy revealed that a single ?2?1 integrin can withstand tensile forces of up to approximately 160pN before it releases FC3. Moreover, FC3 is fully competent to agonistically elicit ?2?1 integrin-induced cell reactions, such as recruitment of ?2?1 integrin into focal adhesions and lamellipodia formation. The biofunctionalized mini-collagen sheds light on the molecular forces of the ?2?1 integrin-collagen interaction, which affects tissue homeostasis by contracting the connective tissue and by contributing to interstitial tissue pressure regulation. Additionally, biofunctionalized mini-collagens can be useful in force-resistant cell attachment to biomedical materials.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1878-5875
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
721-31
|
pubmed:meshHeading |
pubmed-meshheading:21262375-Animals,
pubmed-meshheading:21262375-Binding Sites,
pubmed-meshheading:21262375-Biomechanics,
pubmed-meshheading:21262375-Cattle,
pubmed-meshheading:21262375-Cell Line, Tumor,
pubmed-meshheading:21262375-Collagen Type I,
pubmed-meshheading:21262375-Extracellular Matrix,
pubmed-meshheading:21262375-Humans,
pubmed-meshheading:21262375-Integrin alpha2beta1,
pubmed-meshheading:21262375-Microscopy, Atomic Force,
pubmed-meshheading:21262375-Protein Structure, Secondary,
pubmed-meshheading:21262375-Recombinant Proteins,
pubmed-meshheading:21262375-Repetitive Sequences, Amino Acid
|
pubmed:year |
2011
|
pubmed:articleTitle |
Biofunctionalization of a generic collagenous triple helix with the ?2?1 integrin binding site allows molecular force measurements.
|
pubmed:affiliation |
Excellence Cluster Cardio-Pulmonary System, Frankfurt University Hospital, Frankfurt/Main, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|